Author:
Abbott Frank S.,Anari M. Reza
Reference170 articles.
1. Di Carlo FJ, Bickart P, Auer CM (1986) Structure-metabolism relationships (SMR) for the prediction of health hazards by the Environmental Protection Agency. II. Application to teratogenicity and other toxic effects caused by aliphatic acids. Drug Metab Rev 17: 187–220
2. Loscher W (1981) Anticonvulsant activity of metabolites of valproic acid. Arch Int Pharmacodyn Ther 249: 158–63
3. Rettie AE, Rettenmeier AW, Howald WN, Baillie TA (1987) Cytochrome P-450-catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid. Science 235: 890–3
4. Liu MJ, Brouwer KL, Pollack GM (1992) Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-l-cyclohexanecarboxylic acid in the bile-exteriorized rat. Drug Metab Dispos 20: 810–5
5. Bialer M, Hadad S, Kadry B, Abdul-Hai A, Haj-Yehia A, Sterling J, Herzig Y, Yagen B (1996) Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide. Pharm Res 13: 284–9
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献